Erba Diagnostics (IVD) Return on Equity ROE from the first quarter 2015 to first quarter 2012 and annually, average high and low, overall ranking from Mar 31 2015 to Mar 31 2012 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Erba Diagnostics, Inc.  (IVD)

Erba Diagnostics's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Erba Diagnostics in the first quarter 2015?
Erba Diagnostics, Inc. recorded a cumulative net loss of $-1 million during 12 months ending in the first quarter 2015, resulting in a negative return on equity (ROE) of -4.07%.

Within the Laboratory Analytical Instruments industry 15 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2014 from 2606 to 3078.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2015)
I. Quarter		 (Dec 31 2014)
IV. Quarter		 (Sep 30 2014)
III. Quarter		 (Jun 30 2014)
II. Quarter		 (Mar 31 2012)
I. Quarter
Y / Y Equity Change 57.41 % 69.81 % 65.37 % 46.73 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -1 0 0 -1 -2
Return On Equity (TTM) -4.07 % 1.26 % 3.42 % -6.74 % -18.39 %
IVD's Total Ranking # 3078 # 2606 # 0 # #
Equity (TTM) in Millions 17 18 18 18 11
Seq. Equity Change -6.93 % -1.21 % -0.15 % 71.46 % 0.4 %
Seq. Net Income Change - - -71.6 % - -

Back to IVD Management Effectiveness >> IVD's 5 Years Annual ROE >> Compare IVD ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 16
Sector # 201
Overall # 3078

Return On Equity Statistics
High Average Low
0.67 %
0.67 %
0.67 %
(Sep 30 2014)  





IVD Annual Return On Equity (Dec 31 2014)
2014		 (Dec 31 2011)
2011


Total Equity in Millions 18 11 0 0 0
Y / Y Equity Change 69.81 % - - - -
Net Income in Millions 0 -3 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity 2.47 % -30.74 % - - -

Back to IVD Management Effectiveness >> IVD's 5 Years Annual ROE >> Compare IVD ROE to its Competitors




Annual Roe Comment
In 2014 ROE improved to 2.47 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Laboratory Analytical Instruments Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
IVD's' Return on Equity at Yahoo Finance
IVD's Roe Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for IVD's Competitors
Subscribers only: Roe for Erba Diagnostics's Suppliers
Subscribers only: Return On Equity for IVD's Customers




Companies with similar Return On Equity at Mar 31 2015, within Healthcare Sector ROE

Date modified: 2026-08-30T23:41:52+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.